Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal

British Journal of Pharmacology

Volumn 172, Issue 6, 2015, Pages 1607-1619

  Wesseling, Sebastiaan ^a   Fledderus, Joost O ^a   Verhaar, Marianne C ^a   Joles, Jaap A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

carbon monoxide; cystathionine lyase; haeme oxygenase 1; hydrogen sulfide; hypertension; nitric oxide; renal

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE 1; HYDROGEN SULFIDE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROPARGYLGLYCINE; PROTOPORPHYRIN TIN; UREA; ALKYNE; CYSTATHIONINE GAMMA LYASE; GLYCINE; METALLOPORPHYRIN; PROTOPORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY DYSFUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; RENAL PROTECTION; SYSTOLIC BLOOD PRESSURE; UREA BLOOD LEVEL; UREMIA; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALKYNES; ANIMALS; CARBON MONOXIDE; CYSTATHIONINE GAMMA-LYASE; GLYCINE; HEME OXYGENASE-1; HYDROGEN SULFIDE; HYPERTENSION; KIDNEY; MALE; METALLOPORPHYRINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; PROTOPORPHYRINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84923700203     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12674     Document Type: Article

References (71)

1. Agarwal A, Nick HS, (2000). Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression. J Am Soc Nephrol 11: 965-973.
2. Andrew PJ, Mayer B, (1999). Enzymatic function of nitric oxide synthases. Cardiovasc Res 43: 521-531.
3. Attia DM, Verhagen AM, Stroes ES, van Faassen EE, Grone HJ, De Kimpe SJ, et al. (2001). Vitamin E alleviates renal injury, but not hypertension, during chronic nitric oxide synthase inhibition in rats. J Am Soc Nephrol 12: 2585-2593.
4. Attia DM, Ni ZN, Boer P, Attia MA, Goldschmeding R, Koomans HA, et al. (2002). Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats. Kidney Int 61: 1776-1787.
5. Baylis C, (2008). Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol 294: F1-F9.
6. Baylis C, Vallance P, (1996). Nitric oxide and blood pressure: effects of nitric oxide deficiency. Curr Opin Nephrol Hypertens 5: 80-88.
7. Baylis C, Mitruka B, Deng A, (1992). Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281.
8. Botros FT, Navar LG, (2006). Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles. Am J Physiol Heart Circ Physiol 291: H2772-H2778.
9. Carter EP, Hartsfield CL, Miyazono M, Jakkula M, Morris KG Jr, McMurtry IF, (2002). Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol 283: L346-L353.
10. Chandrashekar K, Lopez-Ruiz A, Juncos R, Nath K, Stec DE, Vera T, et al. (2012). The modulatory role of heme oxygenase on subpressor angiotensin ii-induced hypertension and renal injury. Int J Hypertens 2012: 392890.
11. Chok MK, Ferlicot S, Conti M, Almolki A, Durrbach A, Loric S, et al. (2009). Renoprotective potency of heme oxygenase-1 induction in rat renal ischemia-reperfusion. Inflamm Allergy Drug Targets 8: 252-259.
12. Christodoulides N, Durante W, Kroll MH, Schafer AI, (1995). Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 91: 2306-2309.
13. Coletta C, Papapetropoulos A, Erdelyi K, Olah G, Modis K, Panopoulos P, et al. (2012). Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proc Natl Acad Sci U S A 109: 9161-9166.
14. Correa-Costa M, Semedo P, Monteiro AP, Silva RC, Pereira RL, Goncalves GM, et al. (2010). Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. PLoS ONE 5: e14298.
15. D'Araio E, Shaw N, Millward A, Demaine A, Whiteman M, Hodgkinson A, (2014). Hydrogen sulfide induces heme oxygenase-1 in human kidney cells. Acta Diabetol 51: 155-157.
16. Datta PK, Reddy S, Sharma M, Lianos EA, (2006). Differential nephron HO-1 expression following glomerular epithelial cell injury. Nephron Exp Nephrol 103: e131-e138.
17. Gadalla MM, Snyder SH, (2010). Hydrogen sulfide as a gasotransmitter. J Neurochem 113: 14-26.
18. Huber WJ 3rd, Marohnic CC, Peters M, Alam J, Reed JR, Masters BS, et al. (2009). Measurement of membrane-bound human heme oxygenase-1 activity using a chemically defined assay system. Drug Metab Dispos 37: 857-864.
19. Issa K, Kimmoun A, Collin S, Ganster F, Fremont-Orlowski S, Asfar P, et al. (2013). Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusion injury. Crit Care 17: R129.
20. Jadhav A, Torlakovic E, Ndisang JF, (2009). Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol Renal Physiol 296: F521-F534.
21. Jin HF, Du JB, Li XH, Wang YF, Liang YF, Tang CS, (2006). Interaction between hydrogen sulfide/cystathionine gamma-lyase and carbon monoxide/heme oxygenase pathways in aortic smooth muscle cells. Acta Pharmacol Sin 27: 1561-1566.
22. Kaizu T, Tamaki T, Tanaka M, Uchida Y, Tsuchihashi S, Kawamura A, et al. (2003). Preconditioning with tin-protoporphyrin IX attenuates ischemia/reperfusion injury in the rat kidney. Kidney Int 63: 1393-1403.
23. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
24. Koeners MP, Braam B, van der Giezen DM, Goldschmeding R, Joles JA, (2008). A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats. Am J Physiol Regul Integr Comp Physiol 294: R1847-R1855.
25. Konno R, Ikeda M, Yamaguchi K, Ueda Y, Niwa A, (2000). Nephrotoxicity of D-proparglyglycine in mice. Arch Toxicol 74: 473-479.
26. van Koppen A, Verhaar MC, Bongartz LG, Joles JA, (2013). 5/6th nephrectomy in combination with high salt diet and nitric oxide synthase inhibition to induce chronic kidney disease in the Lewis rat. J Vis Exp 77: e50398.
27. Lentz SR, Erger RA, Dayal S, Maeda N, Malinow MR, Heistad DD, et al. (2000). Folate dependence of hyperhomocysteinemia and vascular dysfunction in cystathionine beta-synthase-deficient mice. Am J Physiol Heart Circ Physiol 279: H970-H975.
28. Li L, Hsu A, Moore PK, (2009). Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation-a tale of three gases! Pharmacol Ther 123: 386-400.
29. Liu S, Shi L, Liu X, (2004). Effect of heme oxygenase-1 inducer hemin on chronic renal failure rats. J Huazhong Univ Sci Technolog Med Sci 24: 250-253.
30. Liu YH, Yan CD, Bian JS, (2011). Hydrogen sulfide: a novel signaling molecule in the vascular system. J Cardiovasc Pharmacol 58: 560-569.
31. Maekawa M, Okamura T, Kasai N, Hori Y, Summer KH, Konno R, (2005). D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity. Chem Res Toxicol 18: 1678-1682.
32. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
33. Meng J, Ganesan Adaikan P, Srilatha B, (2013). Hydrogen sulfide promotes nitric oxide production in corpus cavernosum by enhancing expression of endothelial nitric oxide synthase. Int J Impot Res 25: 86-90.
34. Modis K, Wolanska K, Vozdek R, (2013). Hydrogen sulfide in cell signaling, signal transduction, cellular bioenergetics and physiology in C. elegans. Gen Physiol Biophys 32: 1-22.
35. Nakao A, Faleo G, Shimizu H, Nakahira K, Kohmoto J, Sugimoto R, et al. (2008). Ex vivo carbon monoxide prevents cytochrome P450 degradation and ischemia/reperfusion injury of kidney grafts. Kidney Int 74: 1009-1016.
36. Nath KA, (2013). The role of renal research in demonstrating the protective properties of heme oxygenase-1. Kidney Int 84: 3-6.
37. Ndisang JF, Lane N, Syed N, Jadhav A, (2010). Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology 151: 549-560.
38. Oh GS, Pae HO, Lee BS, Kim BN, Kim JM, Kim HR, et al. (2006). Hydrogen sulfide inhibits nitric oxide production and nuclear factor-kappaB via heme oxygenase-1 expression in RAW264.7 macrophages stimulated with lipopolysaccharide. Free Radic Biol Med 41: 106-119.
39. Ortiz PA, Garvin JL, (2003). Cardiovascular and renal control in NOS-deficient mouse models. Am J Physiol Regul Integr Comp Physiol 284: R628-R638.
40. Pedraza-Chaverri J, Murali NS, Croatt AJ, Alam J, Grande JP, Nath KA, (2006). Proteinuria as a determinant of renal expression of heme oxygenase-1: studies in models of glomerular and tubular proteinuria in the rat. Am J Physiol Renal Physiol 290: F196-F204.
41. Polizio AH, Santa-Cruz DM, Balestrasse KB, Gironacci MM, Bertera FM, Hocht C, et al. (2011). Heme oxygenase-1 overexpression fails to attenuate hypertension when the nitric oxide synthase system is not fully operative. Pharmacology 87: 341-349.
42. Prabhakar NR, (2012). Carbon monoxide (CO) and hydrogen sulfide (H(2)S) in hypoxic sensing by the carotid body. Respir Physiol Neurobiol 184: 165-169.
43. Ptilovanciv EO, Fernandes GS, Teixeira LC, Reis LA, Pessoa EA, Convento MB, et al. (2013). Heme oxygenase 1 improves glucoses metabolism and kidney histological alterations in diabetic rats. Diabetol Metab Syndr 5: 3.
44. Quan S, Yang L, Abraham NG, Kappas A, (2001). Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc Natl Acad Sci U S A 98: 12203-12208.
45. Rajapakse NW, Mattson DL, (2013). Role of cellular L-arginine uptake and nitric oxide production on renal blood flow and arterial pressure regulation. Curr Opin Nephrol Hypertens 22: 45-50.
46. Reed JR, Huber WJ 3rd, Backes WL, (2010). Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase. Drug Metab Dispos 38: 2060-2066.
47. Rodriguez F, Lamon BD, Gong W, Kemp R, Nasjletti A, (2004). Nitric oxide synthesis inhibition promotes renal production of carbon monoxide. Hypertension 43: 347-351.
48. Rong-na L, Xiang-jun Z, Yu-han C, Ling-qiao L, Gang H, (2011). Interaction between hydrogen sulfide and nitric oxide on cardiac protection in rats with metabolic syndrome. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 33: 25-32.
49. Roy A, Khan AH, Islam MT, Prieto MC, Majid DS, (2012). Interdependency of cystathione gamma-lyase and cystathione beta-synthase in hydrogen sulfide-induced blood pressure regulation in rats. Am J Hypertens 25: 74-81.
50. Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K, et al. (2000). Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278: F726-F736.
51. Singh S, Madzelan P, Banerjee R, (2007). Properties of an unusual heme cofactor in PLP-dependent cystathionine beta-synthase. Nat Prod Rep 24: 631-639.
52. Sun Q, Collins R, Huang S, Holmberg-Schiavone L, Anand GS, Tan CH, et al. (2009). Structural basis for the inhibition mechanism of human cystathionine gamma-lyase, an enzyme responsible for the production of H(2)S. J Biol Chem 284: 3076-3085.
53. Szabo C, Papapetropoulos A, (2011). Hydrogen sulphide and angiogenesis: mechanisms and applications. Br J Pharmacol 164: 853-865.
54. Thorup C, Jones CL, Gross SS, Moore LC, Goligorsky MS, (1999). Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. Am J Physiol 277 (6 Pt 2): F882-F889.
55. Trakshel GM, Sluss PM, Maines MD, (1992). Comparative effects of tin- and zinc-protoporphyrin on steroidogenesis: tin-protoporphyrin is a potent inhibitor of cytochrome P-450-dependent activities in the rat adrenals. Pediatr Res 31: 196-201.
56. Tripatara P, Patel NS, Collino M, Gallicchio M, Kieswich J, Castiglia S, et al. (2008). Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction. Lab Invest 88: 1038-1048.
57. Ushiyama M, Morita T, Katayama S, (2002). Carbon monoxide regulates blood pressure cooperatively with nitric oxide in hypertensive rats. Heart Vessels 16: 189-195.
58. Verhagen AM, Rabelink TJ, Braam B, Opgenorth TJ, Grone HJ, Koomans HA, et al. (1998). Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition. J Am Soc Nephrol 9: 755-762.
59. Verhagen AM, Braam B, Boer P, Grone HJ, Koomans HA, Joles JA, (1999). Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations. Kidney Int 56: 222-231.
60. Verhagen AM, Koomans HA, Joles JA, (2001). Predisposition of spontaneously hypertensive rats to develop renal injury during nitric oxide synthase inhibition. Eur J Pharmacol 411: 175-180.
61. Wang R, Shamloul R, Wang X, Meng Q, Wu L, (2006). Sustained normalization of high blood pressure in spontaneously hypertensive rats by implanted hemin pump. Hypertension 48: 685-692.
62. Washtien W, Abeles RH, (1977). Mechanism of inactivation of gamma-cystathionase by the acetylenic substrate analogue propargylglycine. Biochemistry 16: 2485-2491.
63. Wesseling S, Joles JA, van Goor H, Bluyssen HA, Kemmeren P, Holstege FC, et al. (2007). Transcriptome-based identification of pro- and antioxidative gene expression in kidney cortex of nitric oxide-depleted rats. Physiol Genomics 28: 158-167.
64. Whiting C, Castillo A, Haque MZ, Majid DS, (2013). Protective role of the endothelial isoform of nitric oxide synthase in angiotensin II induced inflammatory responses in the kidney. Am J Physiol Renal Physiol 305: F1031-F1041.
65. Wiesel P, Patel AP, Carvajal IM, Wang ZY, Pellacani A, Maemura K, et al. (2001). Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice. Circ Res 88: 1088-1094.
66. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, et al. (2008). H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322: 587-590.
67. Ying L, Flamant M, Vandermeersch S, Boffa JJ, Chatziantoniou C, Dussaule JC, et al. (2003). Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats. Hypertension 42: 937-944.
68. Zatz R, Baylis C, (1998). Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964.
69. Zatz R, de Nucci G, (1991). Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol 261 (2 Pt 2): F360-F363.
70. Zhao W, Ndisang JF, Wang R, (2003). Modulation of endogenous production of H2S in rat tissues. Can J Physiol Pharmacol 81: 848-853.
71. Zhu JC, Shao JL, Ma H, Wang JK, (2008). Interaction between endogenous cystathionine synthase/hydrogen sulfide and heme oxygenase-1/.carbon monoxide systems during myocardial ischemic-reperfusion: experiment with rats]. Zhonghua Yi Xue Za Zhi 88: 3222-3225.